Literature DB >> 21118860

Decreasing trends in the incidence of heart failure after acute myocardial infarction from 1993-2004: a study of 175,216 patients with a first acute myocardial infarction in Sweden.

Masoud Shafazand1, Annika Rosengren, Georgios Lappas, Karl Swedberg, Maria Schaufelberger.   

Abstract

AIMS: To investigate temporal trends in the risk of heart failure (HF) complicating acute myocardial infarction (AMI) and to determine whether these trends differ by gender or age. METHODS AND
RESULTS: The national Swedish hospital discharge and death registries from 1993 to 2004 were used to calculate age- and gender-specific trends for a first episode of HF within 3 years in 175 216 patients aged 35-84 and hospitalized with a first AMI. Overall, 14.4% of patients aged 35-64 and 31.5% of those aged 65-84 with AMI in 1993-1995 had a hospital diagnosis of HF within 3 years (including the index admission). Corresponding figures for patients with AMI from 2002 to 2004 were 11.5 and 28.0%, respectively. In multivariable analyses, the risk of HF decreased by 4% per year. Having had a stroke before admission increased HF risk by 37%, diabetes increased the risk by 76% and atrial fibrillation by 80%. Patients with any kind of valvular disease had a more than doubled risk. Women had a 6% higher incidence of HF than men, whereas men with an index admission for AMI who did not develop HF had higher mortality than women.
CONCLUSIONS: In this national sample, we observed a steady decrease in the risk of being hospitalized with HF after an AMI. However, the 3-year risk of HF remains high, with nearly one-third of AMI patients aged 65-84 developing HF within 3 years.

Entities:  

Mesh:

Year:  2010        PMID: 21118860     DOI: 10.1093/eurjhf/hfq205

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  17 in total

1.  Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study.

Authors:  Yariv Gerber; Susan A Weston; Cecilia Berardi; Sheila M McNallan; Ruoxiang Jiang; Margaret M Redfield; Véronique L Roger
Journal:  Am J Epidemiol       Date:  2013-08-29       Impact factor: 4.897

2.  National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.

Authors:  Jersey Chen; Sharon-Lise T Normand; Yun Wang; Harlan M Krumholz
Journal:  JAMA       Date:  2011-10-19       Impact factor: 56.272

3.  The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  J Cardiol       Date:  2018-02-01       Impact factor: 3.159

4.  The aging population in Sweden: can declining incidence rates in MI, stroke and cancer counterbalance the future demographic challenges?

Authors:  Karin Modig; Sven Drefahl; Tomas Andersson; Anders Ahlbom
Journal:  Eur J Epidemiol       Date:  2012-02-18       Impact factor: 8.082

5.  Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians' Health Study.

Authors:  Chisa Matsumoto; Naomi Q Hanson; Michael Y Tsai; Robert J Glynn; J Michael Gaziano; Luc Djoussé
Journal:  Clin Nutr       Date:  2013-02-19       Impact factor: 7.324

Review 6.  Epidemiology of heart failure.

Authors:  Véronique L Roger
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

7.  Body weight in midlife and long-term risk of developing heart failure-a 35-year follow-up of the primary prevention study in Gothenburg, Sweden.

Authors:  Lena Björck; Masuma Novak; Maria Schaufelberger; Kok Wai Giang; Annika Rosengren
Journal:  BMC Cardiovasc Disord       Date:  2015-03-10       Impact factor: 2.298

8.  Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden.

Authors:  Anders Barasa; Maria Schaufelberger; Georgios Lappas; Karl Swedberg; Mikael Dellborg; Annika Rosengren
Journal:  Eur Heart J       Date:  2013-07-29       Impact factor: 29.983

9.  Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation.

Authors:  Torbjørn Wisløff; Gunhild Hagen; Marianne Klemp
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

10.  Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia.

Authors:  Joseph Hung; Tiew-Hwa Katherine Teng; Judith Finn; Matthew Knuiman; Thomas Briffa; Simon Stewart; Frank M Sanfilippo; Steven Ridout; Michael Hobbs
Journal:  J Am Heart Assoc       Date:  2013-10-08       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.